ARTV CFO has 3,490 shares withheld for RSU taxes at $3.25

Artiva Biotherapeutics, Inc. reported an insider equity transaction by its Chief Financial Officer, Neha Krishnamohan.

Rhea-AI Filing Summary

Artiva Biotherapeutics, Inc. reported an insider equity transaction by its Chief Financial Officer, Neha Krishnamohan. On 11/15/2025, 3,490 shares of common stock were withheld by the company at a price of $3.25 per share to cover income tax obligations related to the vesting of restricted stock unit awards. After this tax withholding, the reporting person beneficially owns 99,356 shares of Artiva common stock directly.

Insider Trade Summary

Exercise Price or Tax Liability: 3,490 shares

Exercise Price or Tax Liability 1 txn

Insider Krishnamohan Neha

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	3,490	$3.25	$11K

Holdings After Transaction: Common Stock — 99,356 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.

FAQ

What insider transaction did ARTV report for its CFO?

Artiva Biotherapeutics, Inc. reported that its Chief Financial Officer, Neha Krishnamohan, had 3,490 shares of common stock withheld on 11/15/2025 to satisfy income tax obligations on vesting restricted stock units.

How many ARTV shares does the CFO own after the reported transaction?

Following the transaction, the CFO beneficially owns 99,356 shares of Artiva Biotherapeutics, Inc. common stock in direct ownership.

What was the price used for the ARTV shares withheld for taxes?

The shares withheld to cover tax obligations were valued at $3.25 per share in the reported transaction.

Was the ARTV insider transaction a sale on the open market?

No. The 3,490 shares represent stock withheld by the issuer to satisfy income tax obligations from vesting restricted stock units, not an open-market sale.

What role does the reporting person hold at Artiva Biotherapeutics (ARTV)?

The reporting person, Neha Krishnamohan, is an officer of Artiva Biotherapeutics, Inc., serving as its Chief Financial Officer.

Is the Form 4 filing for ARTV made by one or multiple reporting persons?

The Form 4 is indicated as being filed by one reporting person, covering the transactions of the company’s Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 08:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krishnamohan Neha

(Last) (First) (Middle)

C/O ARTIVA BIOTHERAPEUTICS, INC.

5505 MOREHOUSE DRIVE, SUITE 100

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Artiva Biotherapeutics, Inc. [ ARTV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/15/2025		F		3,490(1)	D	$3.25	99,356	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.

	/s/ Neha Krishnamohan	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.